Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2011
03/23/2011CN101392261B Modified highly pathogenic porcine reproductive and respiratory syndrome virus ORF5 gene and application
03/23/2011CN101372672B Normal temperature fermentation Hirsutella hepialid Chen et Shen, mutation breeding method and fermentation process thereof
03/23/2011CN101372512B Anticoagulated blood polypeptides and uses thereof
03/23/2011CN101363041B Quality control substance for detecting chlamydi trachomatis
03/23/2011CN101338312B Pellosil activate fluid and applications thereof for extracting nucleic acid
03/23/2011CN101265480B Conversion method for overcoming agrobacterium tumefaciens mediated wheat immature embryo browning and special culture medium for the same
03/23/2011CN101233232B Novel diglycosidase and gene encoding the same
03/23/2011CN101153332B Primer, detection method and detection reagent kit for detecting cholera vibrio
03/23/2011CN101153326B Primer, detection method and detection reagent kit for detecting shigella
03/23/2011CN101130777B Novel rice gene of encoding zinc finger protein relating to rice growth and disease resistance
03/23/2011CN101070350B Intensified fusion protein NGR-LDP-AE formed by target peptide to CD13 and lidamycin
03/22/2011US7912652 System and method for mutation detection and identification using mixed-base frequencies
03/22/2011US7912651 Function homology screening
03/22/2011US7912650 Information processing system using nucleotide sequence-related information
03/22/2011US7910814 Plants and seeds of hybrid corn variety CH493326
03/22/2011US7910813 Plants and seeds of hybrid corn variety CH918158
03/22/2011US7910812 Plants and seeds of hybrid corn variety CH746441
03/22/2011US7910811 Tomato hybrid BS 01031842
03/22/2011US7910807 Isolated nucleic acid molecule having nucleotide sequence encoding bacillus thuringiensis Cry8Bb1 protoxin with proteolytic activation site cleaved by insect gut protease; expression cassettes; transformed plants and seeds
03/22/2011US7910806 Defensin polynucleotides and methods of use
03/22/2011US7910805 Bacterial glutamine synthetases and methods of use
03/22/2011US7910804 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
03/22/2011US7910803 Transformation in Camelina sativa
03/22/2011US7910802 MSCA1 nucleotide sequences impacting plant male fertility and method of using same
03/22/2011US7910801 Plants with reduced expression of phosphatase type 2C gene for enhanced pathogen resistance
03/22/2011US7910800 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
03/22/2011US7910723 IG20 splice variants therapeutics for cancer
03/22/2011US7910722 RNAi therapeutic for treatment of hepatitis C infection
03/22/2011US7910721 Nucleic acid-enzyme complex
03/22/2011US7910718 Oleosin genes and promoters from coffee
03/22/2011US7910717 Recombinant expression cassettes with a fungal 3′ termination sequence that function in plants
03/22/2011US7910712 Fungal cell wall synthesis gene
03/22/2011US7910711 Human cancer-relating genes, the products encoded thereby and applications thereof
03/22/2011US7910710 DNA enzymes
03/22/2011US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders
03/22/2011US7910707 Anti-interferon-α antibodies
03/22/2011US7910704 Human p53 splice variant displaying differential transcriptional activity
03/22/2011US7910696 Ssx-2 peptides presented by hla class II molecules
03/22/2011US7910567 Opticin nucleic acid administration reduces blood vessel formation
03/22/2011US7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant
03/22/2011US7910563 Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA
03/22/2011US7910562 Method of delivering genes into antigen presenting cells of the skin
03/22/2011US7910554 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
03/22/2011US7910552 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
03/22/2011US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
03/22/2011US7910523 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors
03/22/2011US7910522 Method for the expression of unknown environmental DNA into adapted host cells
03/22/2011US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression
03/22/2011US7910369 Culture systems for ex vivo development
03/22/2011US7910368 Method of extended culture for antigen-specific cytotoxic lymphocytes
03/22/2011US7910366 Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
03/22/2011US7910365 Artificial chimeras engineered to simulate multiple biological threat agents
03/22/2011US7910364 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
03/22/2011US7910363 Lipophilic polyamines providing enhanced intracellular delivery of agents by a polyamine transport system
03/22/2011US7910362 Reporter vector for use in evaluation of CYP1A2 induction
03/22/2011US7910350 Adaptor-directed helper systems
03/22/2011US7910349 Subtilases
03/22/2011US7910347 Perhydrolase providing improved peracid stability
03/22/2011US7910345 Site specific incorporation of keto amino acids into proteins
03/22/2011US7910337 Method for identifying drug-sensitizing antisense DNA fragments and use thereof
03/22/2011US7910331 Nucleic acids encoding murine IL-174
03/22/2011US7910330 Preparing messenger RNA coding plasmodial apical membrane antigen for developing malarial vaccine
03/22/2011US7910329 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
03/22/2011US7910328 A gene having a base sequence existing in introns, where the base sequence initiates transcription of RNA, by external stimulation such as kainic acid or electric stimulation
03/22/2011US7910327 Recombinant alpha-fetoprotein and method of preparing
03/22/2011US7910326 Materials and methods for the modification of plant lignin content
03/22/2011US7910322 Methods for identifying compounds that modulate T1R1/T1R3 umami taste receptors
03/22/2011US7910320 Methods compositions and compound assays for inhibiting amyloid-beta protein production
03/22/2011US7910314 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
03/22/2011US7910300 Disease detection by protein truncation assays
03/22/2011US7910298 Method for a (high through-put) screening detection of genetic modifications in genome engineering
03/22/2011US7910297 Modified aptmer for use in selective treatment and prevention of infection and cell proliferative disorders
03/22/2011US7910294 Based on the combination of a specific ligand/ receptor binding reaction and a detection step involving detection of a nucleic acid marker by amplification and real- time detection of the amplification products
03/22/2011US7910115 Polypeptide absorbable into digestive organs
03/22/2011US7910112 Feline vaccines against avian influenza
03/22/2011US7910110 Bacteriophage-mediated immunisation against hepatitis
03/22/2011US7910109 Major histocompatibility complex epitope for use in treatment and prevention of cell proliferative disorders; immunotherapy
03/22/2011US7910099 Antibodies to VLA-1
03/22/2011US7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof
03/22/2011US7910094 Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
03/22/2011US7910093 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal
03/22/2011CA2510950C Cinnamic acid 4-hydroxylase
03/22/2011CA2498228C Hcv assay
03/22/2011CA2482761C Activation of equine oocytes
03/22/2011CA2461380C Hepatitis c virus vaccine
03/22/2011CA2453008C Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
03/22/2011CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof
03/22/2011CA2444926C Method for labelling and fragmenting dna
03/22/2011CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/22/2011CA2394733C Method for introducing gene into plant having improved transformation efficiency
03/22/2011CA2390166C Hedgehog fusion proteins and uses
03/22/2011CA2354379C Method for isolating dna from biological materials
03/22/2011CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea)
03/22/2011CA2306229C Positive-negative selection for homologous recombination
03/22/2011CA2272844C Novel nucleic acid molecules from maize and their use for the production of modified starch
03/22/2011CA2264483C Method for recombinant adeno-associated virus-directed gene therapy
03/22/2011CA2240409C Mammalian cx3c chemokine genes
03/22/2011CA2236159C Vp antigens of the jc virus
03/22/2011CA2222726C Mutant .alpha.-amylase
03/22/2011CA2173750C Single-chain forms of the glycoprotein hormone quartet